secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0000950170-25-005194
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex Q4 revenue $12.6-12.7M, flat YoY; FY 2024 revenue $48.6-48.7M, down 6%
-----------------------------------------------------------------------------

- Q4 revenue expected $12.6-12.7M vs $12.5M in prior year; sold 47 Cyclo G6 systems (vs 35).
- Full year revenue $48.6-48.7M; down from $51.9M in 2023; system sales dropped to 125 from 164.
- Strategic review remains ongoing with multiple parties for single or multiple transactions.
- Cost restructuring implemented; Q4 achieved positive EBITDA; focus on profitability in 2025.
- Cyclo G6 probe sales flat at 12,700 in Q4; full year 54,800 vs 55,200 in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000095017025005194/0000950170-25-005194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000095017025005194/irix-20250114.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-005194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer